Related Experiment Videos
Endothelium, arachidonic acid, and coronary vascular tone
Insights
Arachidonic acid (AA) metabolites and endothelium-derived factors regulate coronary vascular tone. Cytochrome P-450 metabolites of AA contribute to endothelium-dependent relaxations, while endothelial dysfunction may cause vasospasm.
Area of Science:
- Cardiovascular Physiology
- Vascular Biology
- Pharmacology
Background:
- Vasoactive mediators are crucial for controlling coronary vascular tone.
- Arachidonic acid (AA) metabolites and endothelium-derived factors are key players in coronary vasoregulation.
- AA metabolism occurs via cyclooxygenase, lipoxygenase, and cytochrome P-450 pathways in blood vessels.
Purpose of the Study:
- To investigate the role of AA metabolites, particularly cytochrome P-450 dependent metabolites, in endothelium-dependent relaxations.
- To explore the contribution of various endothelium-derived factors (relaxing and contractile) to coronary vasoregulation.
- To understand the mechanisms underlying endothelial dysfunction and vasospasm, including the role of neutrophil-endothelium interactions.
Main Methods:
- Investigated AA-induced endothelium-dependent relaxations in blood vessels.
- Examined the effects of drugs modulating cytochrome P-450 activity on these relaxations.
- Identified and characterized endothelium-derived relaxing factors (EDRFs) and contractile factors.
- Considered the role of platelet-derived mediators and neutrophil-endothelium interactions in endothelial dysfunction.
Main Results:
- Cytochrome P-450-dependent metabolites of AA contribute to endothelium-dependent relaxations.
- Drugs affecting cytochrome P-450 activity altered AA-induced relaxations, supporting this pathway's role.
- Acetylcholine-induced relaxations do not appear to involve the cytochrome P-450 pathway, suggesting multiple EDRFs.
- Both relaxing (e.g., prostaglandin I2) and contractile endothelium-derived factors exist.
- Endothelial injury and loss of relaxing factors may lead to vasospasm, potentially involving platelet mediators like thromboxane A2 (TXA2).
- Neutrophil-endothelium interactions following ischemia can cause endothelial dysfunction and vasospasm.
Conclusions:
- Cytochrome P-450 metabolites of AA are important endothelium-derived relaxing factors.
- Multiple EDRFs likely exist, with distinct pathways for different stimuli.
- Endothelial dysfunction, potentially involving neutrophil-endothelium interactions and altered balance of vasoactive factors, contributes to vasospasm.
- Conditions like unstable angina may involve these mechanisms, potentially treatable by inhibiting platelet activation and TXA2 formation.
Abstract:
Vasoactive mediators play an important role in the control of coronary vascular tone. Arachidonic acid (AA) metabolites and endothelium-derived vasoactive factors have been implicated in coronary vasoregulation. AA can be metabolized via three separate routes in blood vessels, mediated by cyclooxygenase, lipoxygenase, and cytochrome P-450-dependent monooxygenase enzymes. AA can evoke endothelium-dependent relaxations that are due in part to the formation of cytochrome P-450-dependent metabolites, inasmuch as drugs that modify cytochrome P-450 activity produce parallel changes in endothelium-dependent relaxations to AA. Moreover, some cytochrome P-450-derived metabolites formed biologically cause relaxations of isolated blood vessels. A cytochrome P-450-dependent pathway does not appear to contribute to endothelium-dependent relaxations induced by acetylcholine, which suggests that there may be a number of endothelium-derived relaxing factors (EDRFs). In addition, two endothelium-derived contractile factors have been described, including an unidentified cyclooxygenase metabolite of AA and a polypeptide isolated from cultured cells. As both prostaglandin I2 and acetylcholine-induced EDRF also inhibit platelet aggregation, endothelial injury and loss of these factors may predispose to vasospasm precipitated by release of platelet-derived mediators such as thromboxane A2 (TXA2) and 5-hydroxytryptamine. Unstable angina may be a clinical syndrome in which these events occur, which can be alleviated by inhibition of platelet activation and TXA2 formation with aspirin. Attenuation of endothelium-dependent relaxations can also occur without loss of endothelial cells. Neutrophil-endothelium interactions, precipitated by an ischemic episode, may initiate endothelial dysfunction and underlie the development of vasospasm in some conditions. Whether increased production of endothelium-derived contractile factors also occurs in vasospastic conditions remains to be determined.